Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 87 of the 91 references it cites were found in a registry or an index; 29 of the 95 sources its claims cite were checked for support.

Digital technologies in the public-health response to COVID-19

Open access

Abstract

Digital technologies are being harnessed to support the public-health response to COVID-19 worldwide, including population surveillance, case identification, contact tracing and evaluation of interventions on the basis of mobility data and communication with the public. These rapid responses leverage billions of mobile phones, large online datasets, connected devices, relatively low-cost computing resources and advances in machine learning and natural language processing. This Review aims to capture the breadth of digital innovations for the public-health response to COVID-19 worldwide and their limitations, and barriers to their implementation, including legal, ethical and privacy barriers, as well as organizational and workforce barriers. The future of public health is likely to become increasingly digital, and we review the need for the alignment of international strategies for the regulation, evaluation and use of digital technologies to strengthen pandemic management, and future preparedness for COVID-19 and other infectious diseases.

Overview

CoChat Summary

TL;DR

This is a review of how digital technologies were being used in the COVID-19 response for surveillance, rapid case identification, interrupting transmission, and public communication. The authors argue these tools can strengthen public-health systems, but only as part of an integrated, evaluated, and privacy-preserving strategy.

Key findings

  • The paper identifies four main public-health uses for digital technologies in COVID-19: digital epidemiological surveillance, rapid case identification, interrupting community transmission, and public communication.
  • For surveillance, the authors note that online data systems such as ProMED-mail, GPHIN, HealthMap, EIOS, and EPI-BRAIN are increasingly integrated into formal surveillance; in the UK, confirmed cases represented an estimated 4.7% of symptomatic COVID-19 cases when only hospitalized patients and healthcare workers were routinely tested.
  • For case identification, the paper states that an estimated 80% of COVID-19 cases are mild or asymptomatic, supporting widespread testing and digital symptom reporting; it also reports that the COVID-19 symptom-tracker app had been downloaded by 3.9 million people in the UK and USA.
  • For contact tracing and mobility analysis, the authors note that contact-tracing apps had been launched in at least 40 countries, TraceTogether uptake in Singapore had reached only 30% by June 2020, and one Italian mobility analysis estimated a 50% reduction in total trips between provinces in the week after lockdown announcement.
  • The paper also reports broad digital reach relevant to public messaging: 4.1 billion people accessed the internet and there were 5.2 billion unique mobile subscribers, with 67% of the global population subscribed to mobile devices, 65% of those as smartphones, and 3.8 billion people actively using social media as of January 2020.

Methods

  • Narrative review article synthesizing published studies, preprints, reports, and public datasets on digital technologies used in the COVID-19 public-health response worldwide.
  • Focuses on four functional areas: surveillance, case identification, transmission interruption, and public communication, with examples drawn from specific countries, apps, and data systems.
  • Uses descriptive comparison rather than original experimental analysis or meta-analysis; the main approach is critical synthesis of benefits, limitations, and implementation barriers.

Limitations

  • The paper explicitly states that it is too early to fully quantify the added value of digital technologies to the pandemic response, and that many interventions had not yet been peer-reviewed, rigorously tested, or evaluated with digital health evidence frameworks.
  • The authors state there is no evidence of the effectiveness of COVID-19 contact-tracing apps at the time of writing, including no empirical estimates for case yield, compliance, reduction in R value, or comparison with traditional methods.
  • Evident from the text: because this is a review, conclusions depend on heterogeneous external sources and many examples are presented as early or preliminary, so the strength of evidence varies across technologies.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41591-020-1011-4

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

21 Valid · 3 Not valid · 38 Not checked · 25 Own results and interpretations

27 more claims · 5 with their cited sources checked

Create a free account to see all 87 claims and to verify the 15 references still open.

See all claims — free account
  • It may state two separate claims as one. 41
  • Probably not a substantial claim. 25

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 91 references

Research works printed but not linked: 1

  1. Ada Lovelace Institute. Exit through the App Store? A rapid evidence review on the technical considerations and societal implications of using technology to transition from the COVID-19 crisis. https://www.adalovelaceinstitute.org/our-work/covid-19/covid-19-exit-through-the-app-store/ (2020).

Cited by

See all 1,195

Metadata

Authors
Budd, J., Miller, B. S., Manning, E. M., Lampos, V., Zhuang, M., Edelstein, M., Rees, G., Emery, V. C., Stevens, M. M., Keegan, N., Short, M. J., Pillay, D., Manley, E., Cox, I. J., Heymann, D., Johnson, A. M., & McKendry, R. A.
Affiliations
  • London Centre for Nanotechnology (GB)
  • University College London (GB)
  • Chatham House (GB)
  • University of Surrey (GB)
  • Imperial College London (GB)
  • Newcastle University (GB)
  • Department for International Trade (GB)
  • University of Leeds (GB)
  • University of Copenhagen (DK)
  • London School of Hygiene & Tropical Medicine (GB)
Corresponding author
McKendry, Rachel A.
Venue
Nature Medicine
Published
2020-08-01
Volume
26
Issue
8
Pages
1183-1192
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W3047747926
Cited by
1,195
References
91
Citations by year
2026: 67 · 2025: 140 · 2024: 177 · 2023: 223 · 2022: 279 · 2021: 256 · 2020: 52
FWCI
29.35
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
  • Spiral (Imperial College London) (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
  • RCUK | Engineering and Physical Sciences Research Council (EP/R00529X/1, EP/R018391/1)
  • RCUK | Medical Research Council (MC_PC_19070)
Topics
  • Physical Sciences › Computer Science › Information Systems › COVID-19 Digital Contact Tracing
  • Health Sciences › Medicine › Epidemiology › Data-Driven Disease Surveillance
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
Keywords
COVID-19 pandemic, digital health technologies, public health response, contact tracing, population surveillance, case finding, mobility data, privacy and ethics, implementation barriers, pandemic preparedness, digital health applications, symptom monitoring, machine learning, natural language processing
MeSH terms
Machine Learning, Betacoronavirus, COVID-19, SARS-CoV-2, Humans, Natural Language Processing, Pneumonia, Viral, Population Surveillance, Public Health, Coronavirus Infections, Privacy, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Digital technologies in the public-health response to COVID-19. https://app.cochat.ai/papers/10.1038/s41591-020-1011-4
The paper
Budd, J., Miller, B. S., Manning, E. M., Lampos, V., Zhuang, M., Edelstein, M., Rees, G., Emery, V. C., Stevens, M. M., Keegan, N., Short, M. J., Pillay, D., Manley, E., Cox, I. J., Heymann, D., Johnson, A. M., & McKendry, R. A. (2020). Digital technologies in the public-health response to COVID-19. Nature Medicine. https://doi.org/10.1038/s41591-020-1011-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.